Avita Medical Stock Analysis

RCEL Stock  USD 9.47  0.07  0.74%   
Avita Medical is undervalued with Real Value of 11.2 and Target Price of 17.16. The main objective of Avita Medical stock analysis is to determine its intrinsic value, which is an estimate of what Avita Medical is worth, separate from its market price. There are two main types of Avita Medical's stock analysis: fundamental analysis and technical analysis.
The Avita Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.

Avita Stock Analysis Notes

About 24.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.23. Avita Medical had not issued any dividends in recent years. The entity had 1:5 split on the 30th of June 2020. AVITA Medical, Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. AVITA Medical, Inc. was incorporated in 2000 and is based in Valencia, California. Avita Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 116 people. To find out more about Avita Medical contact James Corbett at 661 367 9170 or learn more at https://www.avitamedical.com.

Avita Medical Quarterly Total Revenue

19.55 Million

Avita Medical Investment Alerts

Avita Medical generated a negative expected return over the last 90 days
Avita Medical has high historical volatility and very poor performance
Avita Medical has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 50.14 M. Net Loss for the year was (35.38 M) with profit before overhead, payroll, taxes, and interest of 51.43 M.
Avita Medical currently holds about 84.17 M in cash with (38.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.67.
Avita Medical has a poor financial position based on the latest SEC disclosures
Latest headline from news.google.com: Acquisition by Otoole David D of 1000 shares of Avita Medical at 10.3 subject to Rule 16b-3

Avita Medical Upcoming and Recent Events

22nd of February 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Avita Largest EPS Surprises

Earnings surprises can significantly impact Avita Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-02-18
2019-12-31-0.03-0.0662-0.0362120 
2021-05-14
2021-03-31-0.3-0.260.0413 
2023-02-23
2022-12-31-0.29-0.220.0724 
View All Earnings Estimates

Avita Medical Environmental, Social, and Governance (ESG) Scores

Avita Medical's ESG score is a quantitative measure that evaluates Avita Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Avita Medical's operations that may have significant financial implications and affect Avita Medical's stock price as well as guide investors towards more socially responsible investments.

Avita Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Nuveen Asset Management, Llc2024-09-30
71.7 K
Charles Schwab Investment Management Inc2024-09-30
70.9 K
D. E. Shaw & Co Lp2024-09-30
67.1 K
Bank Of New York Mellon Corp2024-09-30
53.1 K
Ameriprise Financial Inc2024-09-30
44.3 K
Curi Rmb Capital2024-09-30
43 K
Barclays Plc2024-09-30
37.5 K
Rhumbline Advisers2024-09-30
34.4 K
Bank Of America Corp2024-09-30
32.8 K
Blackrock Inc2024-09-30
1.9 M
Vanguard Group Inc2024-09-30
1.4 M
Note, although Avita Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Avita Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 248.28 M.

Avita Profitablity

The company has Profit Margin (PM) of (0.95) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.71) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.71.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.31)(0.33)
Return On Capital Employed(0.36)(0.38)
Return On Assets(0.31)(0.33)
Return On Equity(0.36)(0.38)

Management Efficiency

Avita Medical has return on total asset (ROA) of (0.4537) % which means that it has lost $0.4537 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5244) %, meaning that it created substantial loss on money invested by shareholders. Avita Medical's management efficiency ratios could be used to measure how well Avita Medical manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.33. The value of Return On Capital Employed is expected to slide to -0.38. At this time, Avita Medical's Net Current Asset Value is quite stable compared to the past year. Tangible Asset Value is expected to rise to about 4.1 M this year, although the value of Intangible Assets will most likely fall to about 416.4 K.
Last ReportedProjected for Next Year
Book Value Per Share 5.73  5.44 
Net Current Asset Value2.2 M2.9 M
Tangible Asset Value2.4 M4.1 M
Tangible Book Value Per Share 5.69  5.41 
Enterprise Value Over EBITDA(4.03)(4.23)
Price Book Value Ratio 1.19  1.13 
Enterprise Value Multiple(4.03)(4.23)
Price Fair Value 1.19  1.13 
Enterprise Value124.9 M131.1 M
Avita Medical benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Operating Margin
(0.71)
Profit Margin
(0.95)
Beta
1.543
Return On Assets
(0.45)
Return On Equity
(1.52)

Technical Drivers

As of the 31st of January, Avita Medical shows the Mean Deviation of 3.15, risk adjusted performance of 0.0214, and Downside Deviation of 7.77. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Avita Medical, as well as the relationship between them. Please confirm Avita Medical jensen alpha, as well as the relationship between the potential upside and skewness to decide if Avita Medical is priced correctly, providing market reflects its regular price of 9.47 per share. Given that Avita Medical has jensen alpha of 0.0632, we suggest you to validate Avita Medical's prevailing market performance to make sure the company can sustain itself at a future point.

Avita Medical Price Movement Analysis

Execute Study
The output start index for this execution was fourty-four with a total number of output elements of seventeen. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Avita Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Avita Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Avita Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Avita Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Avita Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Avita Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Nicole Kelsey over a week ago
Acquisition by Nicole Kelsey of 65000 shares of Avita Medical at 8.73 subject to Rule 16b-3
 
O'toole David D over a week ago
Acquisition by Otoole David D of 1000 shares of Avita Medical at 17.93 subject to Rule 16b-3
 
O'toole David D over two months ago
Acquisition by Otoole David D of 785 shares of Avita Medical at 7.83 subject to Rule 16b-3
 
James Corbett over three months ago
Acquisition by James Corbett of 350000 shares of Avita Medical at 12.64 subject to Rule 16b-3
 
Panaccio Lou over three months ago
Acquisition by Panaccio Lou of 5395 shares of Avita Medical subject to Rule 16b-3
 
Donna Shiroma over three months ago
Acquisition by Donna Shiroma of 20650 shares of Avita Medical at 4.97 subject to Rule 16b-3
 
Mcnamara Robert over three months ago
Acquisition by Mcnamara Robert of 10000 shares of Avita Medical at 9.0 subject to Rule 16b-3
 
Kelsey Nicole over six months ago
Disposition of 150000 shares by Kelsey Nicole of Avita Medical at 7.72 subject to Rule 16b-3
 
Vance Cary Guy over six months ago
Acquisition by Vance Cary Guy of 9200 shares of Avita Medical subject to Rule 16b-3
 
O'toole David D over six months ago
Acquisition by Otoole David D of 1000 shares of Avita Medical at 17.93 subject to Rule 16b-3
 
Cook Jeremy Curnock over six months ago
Acquisition by Cook Jeremy Curnock of 4350 shares of Avita Medical subject to Rule 16b-3
 
Cook Jeremy Curnock over six months ago
Acquisition by Cook Jeremy Curnock of 4350 shares of Avita Medical subject to Rule 16b-3

Avita Medical Outstanding Bonds

Avita Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Avita Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Avita bonds can be classified according to their maturity, which is the date when Avita Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Avita Medical Predictive Daily Indicators

Avita Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Avita Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Avita Medical Corporate Filings

F4
29th of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
22nd of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
7th of January 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
5th of December 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
7th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
20th of August 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
8th of August 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
31st of July 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Avita Medical Forecast Models

Avita Medical's time-series forecasting models are one of many Avita Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Avita Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Avita Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Avita Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Avita shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Avita Medical. By using and applying Avita Stock analysis, traders can create a robust methodology for identifying Avita entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.70)(0.73)
Operating Profit Margin(0.92)(0.96)
Net Loss(0.70)(0.73)
Gross Profit Margin 0.74  0.78 

Current Avita Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Avita analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Avita analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
17.16Strong Buy6Odds
Avita Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Avita analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Avita stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Avita Medical, talking to its executives and customers, or listening to Avita conference calls.
Avita Analyst Advice Details

Avita Stock Analysis Indicators

Avita Medical stock analysis indicators help investors evaluate how Avita Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Avita Medical shares will generate the highest return on investment. By understating and applying Avita Medical stock analysis, traders can identify Avita Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow18.2 M
Long Term Debt39.8 M
Common Stock Shares Outstanding25.7 M
Total Stockholder Equity49.1 M
Tax Provision66 K
Property Plant And Equipment Net4.3 M
Cash22.1 M
Accounts Payable3.8 M
Net Debt17.7 M
50 Day M A11.7444
Total Current Liabilities13.2 M
Non Current Assets Total7.6 M
Non Currrent Assets Other2.5 M
Stock Based Compensation8.4 M
When determining whether Avita Medical is a strong investment it is important to analyze Avita Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avita Medical's future performance. For an informed investment choice regarding Avita Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.23)
Revenue Per Share
2.335
Quarterly Revenue Growth
0.432
Return On Assets
(0.45)
Return On Equity
(1.52)
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.